Exscientia Yönetim

Yönetim kriter kontrolleri 1/4

Exscientia's CEO is Dave Hallett, appointed in Feb 2023, has a tenure of 1.75 years. directly owns 0.001% of the company’s shares, worth $7.35K. The average tenure of the management team and the board of directors is 1.8 years and 3.9 years respectively.

Anahtar bilgiler

Dave Hallett

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresi1.8yrs
CEO sahipliği0.001%
Yönetim ortalama görev süresi1.8yrs
Yönetim Kurulu ortalama görev süresi3.9yrs

Son yönetim güncellemeleri

Recent updates

Recursion's Acquisition Of Exscientia Makes Sense On Some Levels, Not Others

Aug 08

Here's Why We're Watching Exscientia's (NASDAQ:EXAI) Cash Burn Situation

Jul 17
Here's Why We're Watching Exscientia's (NASDAQ:EXAI) Cash Burn Situation

Exscientia: Too Much Pessimism

Jun 10

Exscientia: Drug Discovery Platform Attracting Partners And Cash

May 22

Exscientia: A Strategic Hold In The AI-Driven Drug Discovery Sector (Rating Downgrade)

Feb 26

Is Exscientia (NASDAQ:EXAI) In A Good Position To Invest In Growth?

Jan 11
Is Exscientia (NASDAQ:EXAI) In A Good Position To Invest In Growth?

Earnings Update: Exscientia plc (NASDAQ:EXAI) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Nov 12
Earnings Update: Exscientia plc (NASDAQ:EXAI) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

New Forecasts: Here's What Analysts Think The Future Holds For Exscientia plc (NASDAQ:EXAI)

Aug 31
New Forecasts: Here's What Analysts Think The Future Holds For Exscientia plc (NASDAQ:EXAI)

We're Keeping An Eye On Exscientia's (NASDAQ:EXAI) Cash Burn Rate

Aug 25
We're Keeping An Eye On Exscientia's (NASDAQ:EXAI) Cash Burn Rate

Broker Revenue Forecasts For Exscientia plc (NASDAQ:EXAI) Are Surging Higher

Jul 21
Broker Revenue Forecasts For Exscientia plc (NASDAQ:EXAI) Are Surging Higher

Exscientia (NASDAQ:EXAI) Is In A Good Position To Deliver On Growth Plans

Apr 22
Exscientia (NASDAQ:EXAI) Is In A Good Position To Deliver On Growth Plans

We're Not Very Worried About Exscientia's (NASDAQ:EXAI) Cash Burn Rate

Dec 30
We're Not Very Worried About Exscientia's (NASDAQ:EXAI) Cash Burn Rate

The Exscientia plc (NASDAQ:EXAI) Analysts Have Been Trimming Their Sales Forecasts

Aug 31
The Exscientia plc (NASDAQ:EXAI) Analysts Have Been Trimming Their Sales Forecasts

Exscientia: Using AI To Power Drug Development

Aug 15

Companies Like Exscientia (NASDAQ:EXAI) Can Afford To Invest In Growth

May 29
Companies Like Exscientia (NASDAQ:EXAI) Can Afford To Invest In Growth

Exscientia: Drug Discovery Using AI For Sanofi And Self-Owned Pipeline

Apr 12

Bullish: Analysts Just Made A Sizeable Upgrade To Their Exscientia plc (NASDAQ:EXAI) Forecasts

Jan 09
Bullish: Analysts Just Made A Sizeable Upgrade To Their Exscientia plc (NASDAQ:EXAI) Forecasts

CEO

Dave Hallett (55 yo)

1.8yrs

Görev süresi

Dr. David Hallett, also known as Dave, Ph.D. is the Chief Operations Officer of Exscientia Limited since January 2020. He served as Chief Operating Officer at Exscientia plc since June 2022 until 2022 and...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
David Hallett
Chief Scientific Officer1.8yrsVeri yok0.0012%
$ 7.3k
Ben Taylor
CFO, Chief Strategy Officer & Executive Director4yrsUK£1.92m0.062%
$ 392.2k
John Overington
Chief Technology Officerless than a yearVeri yok0.015%
$ 96.0k
Sara Sherman
Vice President of Investor Relationsno dataVeri yokVeri yok
Dan Ireland
Executive VP of Legal & Company Secretary1.8yrsVeri yokVeri yok
Parker Moss
Executive Vice President of Corporate Developmentless than a yearVeri yokVeri yok
Caroline Rowland
Chief People Officer2.2yrsVeri yokVeri yok
Richard Law
Chief Business Officerno dataVeri yokVeri yok
Nikolaus Krall
Executive Vice President of Precision Medicine1.8yrsVeri yokVeri yok
Marie-Louise Fjallskog
Interim Chief Medical Officer & Clinical Development Leadless than a yearVeri yokVeri yok

1.8yrs

Ortalama Görev Süresi

55yo

Ortalama Yaş

Deneyimli Yönetim: EXAI's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
David Hallett
Chief Scientific Officerless than a yearVeri yok0.0012%
$ 7.3k
Ben Taylor
CFO, Chief Strategy Officer & Executive Director4yrsUK£1.92m0.062%
$ 392.2k
Elizabeth Crain
Independent Non-Executive Chairman3.8yrsUK£282.03k0.089%
$ 564.4k
Mario Polywka
Independent Non-Executive Director7.2yrsUK£201.69k0.053%
$ 334.4k
Robert Ghenchev
Independent Non-Executive Director4.5yrsVeri yokVeri yok
Franziska Michor
Independent Director1.5yrsUK£178.86k0.028%
$ 177.9k

3.9yrs

Ortalama Görev Süresi

51yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: EXAI's board of directors are considered experienced (3.9 years average tenure).